{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:31Z","timestamp":1787003851417,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,7,20]],"date-time":"2004-07-20T00:00:00Z","timestamp":1090281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1038\/sj.bjc.6602040","type":"journal-article","created":{"date-parts":[[2004,7,20]],"date-time":"2004-07-20T13:30:51Z","timestamp":1090330251000},"page":"850-854","source":"Crossref","is-referenced-by-count":82,"title":["Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients"],"prefix":"10.1038","volume":"91","author":[{"given":"P L","family":"Zinzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Stefoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Alinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Farsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Musuraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Canini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Monetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,20]]},"reference":[{"key":"BF6602040_CR1","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma (1993) The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 32: 987\u2013994","DOI":"10.1056\/NEJM199309303291402"},{"key":"BF6602040_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1200\/JCO.1986.4.2.160","volume":"4","author":"JO Armitage","year":"1986","unstructured":"Armitage JO, Weisenburger DD, Hutchins M, Moravec DF, Dowling M, Sorensen S, Mailliard J, Okerbloom J, Johnson PS, Howe D (1986) Chemotherapy for diffuse large-cell lymphoma-rapidly responding patients have more durable remissions. J Clin Oncol 4: 160\u2013164","journal-title":"J Clin Oncol"},{"key":"BF6602040_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.leu.2402342","volume":"16","author":"A Becherer","year":"2002","unstructured":"Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Potzi C, Raderer M, Dudczak R, Kletter K (2002) Positron emission tomography with [18F]2-flouro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia 16: 260\u2013267","journal-title":"Leukemia"},{"key":"BF6602040_CR4","first-page":"769","volume":"61","author":"G Bonadonna","year":"1977","unstructured":"Bonadonna G, Zucali R, De Lena M, Valagussa P (1977) Combined chemotherapy (MOPP or ABVD)\u2013radiotherapy approach in advanced Hodgkin's disease. Cancer Treat Rep 61: 769\u2013777","journal-title":"Cancer Treat Rep"},{"issue":"4","key":"BF6602040_CR5","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"Bruce D. Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (2000) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. (J Clin Oncol 1999; 17: 1244; Erratum in J Clin Oncol 18: 2351)","journal-title":"Journal of Clinical Oncology"},{"key":"BF6602040_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/00006231-199811000-00005","volume":"19","author":"U Cremerius","year":"1998","unstructured":"Cremerius U, Fabry U, Neuerburg J, Zimny M, Osieka R, Bull U (1998) Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Nucl Med Commun 19: 1055\u20131063","journal-title":"Nucl Med Commun"},{"key":"BF6602040_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/s-0038-1623988","volume":"40","author":"U Cremerius","year":"2001","unstructured":"Cremerius U, Fabry U, Neuerburg J, Zimmy M, Bares R, Osieka R, Bull U (2001) Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma. Nuklearmedizin 40: 23\u201330","journal-title":"Nuklearmedizin"},{"key":"BF6602040_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/sj.bmt.1703607","volume":"30","author":"U Cremerius","year":"2002","unstructured":"Cremerius U, Fabry U, Wildberger JE, Zimny M, Reinartz P Nowak B, Schaefer W, Buell U, Osieka R (2002) Pretransplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non Hodgkin's lymphoma. Bone Marrow Transplant 30: 103\u2013111","journal-title":"Bone Marrow Transplant"},{"key":"BF6602040_CR9","volume-title":"Cancer","author":"VT DeVita Jr","year":"1997","unstructured":"DeVita Jr VT, Mauch PM, Harris NL (1997) Hodgkin's disease. In Cancer, DeVita Jr VT, Hellman S, Rosenberg SA (eds). 5th edn, Vol 224 Philadelphia: Lippincott"},{"key":"BF6602040_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/A:1008357126404","volume":"12","author":"M de Wit","year":"2001","unstructured":"de Wit M, Bohuslavizki KH, Buchert R, Bumann D, Clausen M, Hossfeld DK (2001) 18 FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma. Ann Oncol 12: 29\u201337","journal-title":"Ann Oncol"},{"key":"BF6602040_CR11","first-page":"1393","volume":"8","author":"H Dittmann","year":"2001","unstructured":"Dittmann H, Sokler M, Kollmannsberger C, Dohmen BM, Baumann C, Kopp A, Bares R, Claussen CD, Kanz L, Bokemeyer C (2001) Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma. Oncol Rep 8: 1393\u20131399","journal-title":"Oncol Rep"},{"key":"BF6602040_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1378\/chest.124.2.608","volume":"124","author":"JE Fihnont","year":"2003","unstructured":"Fihnont JE, Czenin J, Yap C (2003) Value of f-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest 124: 608\u2013613","journal-title":"Chest"},{"key":"BF6602040_CR13","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","volume":"336","author":"AM Gianni","year":"1997","unstructured":"Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G (1997) High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336: 1290\u20131297","journal-title":"N Engl J Med"},{"key":"BF6602040_CR14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361\u20131392","journal-title":"Blood"},{"key":"BF6602040_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's disease. N Engl J Med 339: 1506\u20131514","journal-title":"N Engl J Med"},{"key":"BF6602040_CR16","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1200\/JCO.1993.11.11.2273","volume":"11","author":"M Hill","year":"1993","unstructured":"Hill M, Cunningham D, MacVicar D, Roldan A, Husband J, McCready R, Mansi J, Milan S, Hickish T (1993) Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J Clin Oncol 11: 2273\u20132278","journal-title":"J Clin Oncol"},{"key":"BF6602040_CR17","first-page":"266","volume":"86","author":"G Jerusalem","year":"2001","unstructured":"Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G (2001) Whole-body positron emission tomography using 18 F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's diseas. Haematologica 86: 266\u2013273","journal-title":"Haematologica"},{"key":"BF6602040_CR18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.V94.2.429","volume":"94","author":"G Jerusalem","year":"1999","unstructured":"Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G (1999) Whole-body positron emission tomography using 18 F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 94: 429\u2013433","journal-title":"Blood"},{"key":"BF6602040_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"ES Kaplan","year":"1958","unstructured":"Kaplan ES, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF6602040_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","volume":"102","author":"P Klimo","year":"1985","unstructured":"Klimo P, Connors JM (1985) MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 102: 596\u2013602","journal-title":"Ann Intern Med"},{"key":"BF6602040_CR21","first-page":"345","volume":"33","author":"L Kostakoglu","year":"1992","unstructured":"Kostakoglu L, Yeh SD, Portlock C, Heelan R, Yao TJ, Niedzwiecki D, Larson SM (1992) Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 33: 345\u2013350","journal-title":"J Nucl Med"},{"key":"BF6602040_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1007\/s002590000340","volume":"27","author":"L Kostakoglu","year":"2000","unstructured":"Kostakoglu L, Goldsmith SJ (2000) Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Eur J Nucl Med 27: 1564\u20131578","journal-title":"Eur J Nucl Med"},{"key":"BF6602040_CR23","first-page":"719","volume":"22","author":"H Mantel","year":"1959","unstructured":"Mantel H, Haenzel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"BF6602040_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1365-2141.2001.03147.x","volume":"115","author":"R Naumann","year":"2001","unstructured":"Naumann R, Vaic A, Beuthien-Baumann B, Bredow J, Kropp J, Kittner T, Franke WG, Ehninger G (2001) Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol 115: 793\u2013800","journal-title":"Br J Haematol"},{"key":"BF6602040_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"BF6602040_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00006231-199705000-00004","volume":"18","author":"FJ Setoain","year":"1997","unstructured":"Setoain FJ, Pons F, Herranz R, Vidal-Sicart S, Lomena F, Ayuso C, Montserrat E, Setoain J (1997) 67 Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma. Nucl Med Commun 18: 405\u2013411","journal-title":"Nucl Med Commun"},{"key":"BF6602040_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","volume":"19","author":"K Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, Vanuytsel L, Bormans G, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G (2001a) Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18 F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18 F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 19: 414\u2013419","journal-title":"J Clin Oncol"},{"key":"BF6602040_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1046\/j.1365-2141.2001.03169.x","volume":"115","author":"K Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, Thomas J, Vandenberghe P, Balzarini J, De Wolf-Peeters C, Motelmans L, Verhoef G (2001b) Can positron emission tomography with [(18) F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br J Haematol 115: 272\u2013278","journal-title":"Br J Haematol"},{"key":"BF6602040_CR29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/annonc\/mdf256","volume":"13","author":"K Spaepen","year":"2002","unstructured":"Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G (2002) Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 13: 1356\u20131363","journal-title":"Ann Oncol"},{"key":"BF6602040_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood-2002-12-3842","volume":"102","author":"K Spaepen","year":"2003","unstructured":"Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Maertens J, Bormans G, Thomas J, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood 102: 53\u201359","journal-title":"Blood"},{"key":"BF6602040_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00259-003-1168-3","volume":"30","author":"D Visvikis","year":"2003","unstructured":"Visvikis D, Ell PJ (2003) Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives. Eur J Nucl Med Mol Imaging 30: 106\u2013116","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF6602040_CR32","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1182\/blood.V98.10.2930","volume":"98","author":"MR Weihrauch","year":"2001","unstructured":"Weihrauch MR, Re D, Scheidhauer K, Ansen S, Dietlein M, Bischoff S, Bohlen H, Wolf J, Schicha H, Diehl V, Tesch H (2001) Thoracic positron emission tomography using 18 F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood 98: 2930\u20132934","journal-title":"Blood"},{"key":"BF6602040_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1042819021000040251","volume":"44","author":"MR Weihrauch","year":"2003","unstructured":"Weihrauch MR, Dietlein M, Schicha H, Diehl V, Tesch H (2003) Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphoma. Leuk Lymphoma 44: 15\u201322","journal-title":"Leuk Lymphoma"},{"key":"BF6602040_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/10428199609051740","volume":"22","author":"PL Zinzani","year":"1996","unstructured":"Zinzani PL, Zompatori M, Bendandi M, Battista G, Fanti S, Barbieri E, Gherlinzoni F, Rimondi MR, Frezza G, Pisi P, Merla E, Gozzetti A, Canini R, Monetti N, Babini L, Tura S (1996) Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 22: 131\u2013135","journal-title":"Leuk Lymphoma"},{"key":"BF6602040_CR35","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V94.10.3289.422k32_3289_3293","volume":"94","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, Bendandi M, Martelli MP, Ascani S, Orcioni GF, Pileri SA, Mandelli F, Tura S (1999a) Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by 67-Gallium scan in 50 patients. Blood 94: 3289\u20133293","journal-title":"Blood"},{"key":"BF6602040_CR36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1023\/A:1008327127033","volume":"10","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Chierichetti F, Zompatori M, Garraffa G, Bendandi M, Gherlinzoni F, Cellini C, Stefoni V, Ferlin G, Tura S (1999b) The role of positron emission tomography (PET) in the management of lymphoma patients. Ann Oncol 10: 1181\u20131184","journal-title":"Ann Oncol"},{"key":"BF6602040_CR37","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/10428190290021704","volume":"43","author":"PL Zinzani","year":"2002","unstructured":"Zinzani PL, Chierichetti F, Zompatori M, Tani M, Stefoni V, Garraffa G, Albertini P, Alinari L, Ferlin G, Baccarani M, Tura S (2002) Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation. Leuk Lymphoma 43: 1239\u20131243","journal-title":"Leuk Lymphoma"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602040","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:11:03Z","timestamp":1684397463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,20]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BF6602040"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602040","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,20]]}}}